• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌组织学亚型的表皮生长因子受体状态

Epidermal growth factor receptor status of histological sub-types of breast cancer.

作者信息

Sainsbury J R, Nicholson S, Angus B, Farndon J R, Malcolm A J, Harris A L

机构信息

Department of Surgery, University of Newcastle upon Tyne, UK.

出版信息

Br J Cancer. 1988 Oct;58(4):458-60. doi: 10.1038/bjc.1988.240.

DOI:10.1038/bjc.1988.240
PMID:3207600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246782/
Abstract

The histological breakdown of a consecutive series of 264 surgically resected malignant lesions of the breast was studied. Oestrogen and epidermal growth factor receptor status was quantified and presented along with size and lymph node status of the non-ductal lesions. Those non-ductal tumours containing EGF receptors have all recurred within two years of resection. Twenty-one percent of the lobular carcinomas contained EGF receptors compared to 34% of ductal carcinomas. EGF receptor status appeared to be associated with an increased risk of early recurrence and death whatever the histological sub-type of the breast cancer.

摘要

对连续264例手术切除的乳腺恶性病变进行了组织学分析。对雌激素和表皮生长因子受体状态进行了量化,并与非导管性病变的大小和淋巴结状态一起呈现。那些含有表皮生长因子受体的非导管性肿瘤在切除后两年内均复发。21%的小叶癌含有表皮生长因子受体,而导管癌为34%。无论乳腺癌的组织学亚型如何,表皮生长因子受体状态似乎都与早期复发和死亡风险增加有关。

相似文献

1
Epidermal growth factor receptor status of histological sub-types of breast cancer.乳腺癌组织学亚型的表皮生长因子受体状态
Br J Cancer. 1988 Oct;58(4):458-60. doi: 10.1038/bjc.1988.240.
2
Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas.人乳腺癌不同组织学亚组中表皮生长因子和雌二醇的受体以及胸苷激酶活性
Br J Cancer. 1986 Aug;54(2):271-6. doi: 10.1038/bjc.1986.173.
3
Expression of epidermal growth factor receptor in breast carcinoma.表皮生长因子受体在乳腺癌中的表达。
J Clin Pathol. 1990 May;43(5):385-9. doi: 10.1136/jcp.43.5.385.
4
Epidermal growth factor receptors on human breast cancers.人类乳腺癌上的表皮生长因子受体
Br J Surg. 1985 Mar;72(3):186-8. doi: 10.1002/bjs.1800720309.
5
Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
Eur J Cancer. 1993;29A(3):426-8. doi: 10.1016/0959-8049(93)90401-z.
6
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement.
Eur J Cancer Clin Oncol. 1988 Nov;24(11):1685-90. doi: 10.1016/0277-5379(88)90068-5.
7
Estimation of the epidermal growth factor receptor by the hydroxyapatite method in human breast cancer.采用羟基磷灰石法对人乳腺癌中表皮生长因子受体进行评估。
Eur J Clin Chem Clin Biochem. 1995 Sep;33(9):563-8. doi: 10.1515/cclm.1995.33.9.563.
8
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.表皮生长因子受体的存在作为乳腺癌患者预后不良的一个指标。
J Clin Pathol. 1985 Nov;38(11):1225-8. doi: 10.1136/jcp.38.11.1225.
9
Epidermal growth factor receptor in human breast cancer.人类乳腺癌中的表皮生长因子受体
Recent Results Cancer Res. 1989;113:70-7. doi: 10.1007/978-3-642-83638-1_9.
10
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer.表皮生长因子受体表达作为乳腺癌的预后指标
Eur J Cancer. 1991;27(8):977-80. doi: 10.1016/0277-5379(91)90262-c.

引用本文的文献

1
Phytosphingosine exhibits an anti-epithelial-mesenchymal transition function by the inhibition of EGFR signaling in human breast cancer cells.植物鞘氨醇通过抑制人乳腺癌细胞中的表皮生长因子受体(EGFR)信号传导,发挥抗上皮-间质转化功能。
Oncotarget. 2017 Sep 8;8(44):77794-77808. doi: 10.18632/oncotarget.20783. eCollection 2017 Sep 29.
2
Role of epidermal growth factor receptor in breast cancer.表皮生长因子受体在乳腺癌中的作用。
Breast Cancer Res Treat. 2012 Nov;136(2):331-45. doi: 10.1007/s10549-012-2289-9. Epub 2012 Oct 17.
3
Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study.厄洛替尼治疗经治非小细胞肺癌患者:一项II期研究。
Oncol Lett. 2010 Mar;1(2):335-338. doi: 10.3892/ol_00000059. Epub 2010 Mar 1.
4
Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma.表皮生长因子受体表达在可手术非小细胞肺癌中的预后价值
Multidiscip Respir Med. 2010 Oct 31;5(5):305-11. doi: 10.1186/2049-6958-5-5-305.
5
Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma.可手术切除的非小细胞肺癌中表皮生长因子受体(EGFR)的表达
J Korean Med Sci. 2004 Aug;19(4):529-35. doi: 10.3346/jkms.2004.19.4.529.
6
Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.不同的酪氨酸自磷酸化位点对neu介导的转化具有负向和正向调节作用。
Mol Cell Biol. 1997 Sep;17(9):5410-25. doi: 10.1128/MCB.17.9.5410.
7
Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.人乳腺癌细胞系异种移植作为乳腺癌模型。受体小鼠的免疫生物学特性及几种致瘤细胞系的特征。
Breast Cancer Res Treat. 1996;39(1):69-86. doi: 10.1007/BF01806079.
8
Epidermal growth factor-like activity and epidermal growth factor-receptors in human primary breast cancer.人原发性乳腺癌中的表皮生长因子样活性与表皮生长因子受体
Breast Cancer Res Treat. 1993;26(1):41-7. doi: 10.1007/BF00682698.
9
The prognostic significance of transforming growth factors in human breast cancer.转化生长因子在人类乳腺癌中的预后意义。
Br J Cancer. 1993 Jun;67(6):1408-12. doi: 10.1038/bjc.1993.261.
10
Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.乳腺癌中的表皮生长因子受体:定量免疫细胞化学检测与预后因素的相关性
Breast Cancer Res Treat. 1993;25(3):203-10. doi: 10.1007/BF00689834.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.雌激素受体、转移性疾病部位与复发性乳腺癌的生存情况
Eur J Cancer (1965). 1981 Apr;17(4):449-53. doi: 10.1016/0014-2964(81)90254-1.
3
Insulin receptors in human cancer.人类癌症中的胰岛素受体。
Br J Cancer. 1981 Dec;44(6):917-20. doi: 10.1038/bjc.1981.292.
4
Presence of transforming growth factors in human breast cancer cells.人类乳腺癌细胞中转化生长因子的存在。
Cancer Res. 1984 Sep;44(9):4069-77.
5
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.乳腺肿瘤活检中表皮生长因子结合情况及其与雌激素受体和孕激素受体水平的关系。
Cancer Res. 1984 Aug;44(8):3448-53.
6
Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.表皮生长因子受体的特性及其对培养的人乳腺癌细胞的作用。
Cancer Res. 1984 Aug;44(8):3442-7.
7
Binding sites for epidermal growth factor in human uterine tissues and leiomyomas.人子宫组织和平滑肌瘤中表皮生长因子的结合位点。
J Clin Endocrinol Metab. 1984 May;58(5):880-4. doi: 10.1210/jcem-58-5-880.
8
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.表皮生长因子受体与v-erb-B癌基因蛋白序列的高度相似性。
Nature. 1984;307(5951):521-7. doi: 10.1038/307521a0.
9
Growth hormone binding to cultured human breast cancer cells.生长激素与培养的人乳腺癌细胞的结合。
J Clin Endocrinol Metab. 1984 Jan;58(1):149-56. doi: 10.1210/jcem-58-1-149.
10
Steroid-hormone receptors and survival after first relapse in breast cancer.类固醇激素受体与乳腺癌首次复发后的生存情况
Lancet. 1984 Mar 17;1(8377):588-91. doi: 10.1016/s0140-6736(84)90995-4.